Creating a new generation of ultra-precise, molecularly guided, intraoperative imaging tools for cancer surgery.
InSyte Bio is dedicated to revolutionizing cancer surgery through the development of ultra-precise, molecularly guided, intraoperative imaging tools. Located in San Francisco, California, InSyte Bio aims to eliminate cancer recurrence by ensuring the complete removal of cancer cells during surgery. The company's innovative surgical imaging system is designed to detect cancer cells with unparalleled precision, offering surgeons and oncologists a powerful tool to combat the spread of cancer. InSyte Bio's approach involves integrating an ultra-miniaturized molecular imager directly into surgical instruments, transforming them into highly sensitive imagers capable of operating seamlessly in minimally invasive cavities.
Located in San Francisco, California 94158, US, InSyte Bio is committed to advancing the field of biotechnology and improving patient outcomes through cutting-edge imaging technology. The company's focus on real-time detection during surgery enables more effective and complete cancer removal, leading to better patient outcomes and reduced recurrence rates. InSyte Bio's technology represents a significant advancement in surgical oncology, offering the potential to transform cancer treatment and improve the lives of patients around the world.
InSyte Bio is poised to become a leader in the field of intraoperative imaging, driven by a passion for innovation and a commitment to excellence. Through its groundbreaking technology, InSyte Bio is empowering surgeons and oncologists to achieve better outcomes in cancer surgery, ultimately improving the lives of patients and families affected by this disease. We invite the management team at InSyte Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative solutions.
Compare InSyte Bio with 3 companies in Biotechnology-Research
| Comparison Field |
InSyte BioMain Company |
HudsonAlpha Institut...View Profile |
The Quantum Light-Ma...View Profile |
Molecular Targeting...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2005 | 2021 | 2011 |
|
Company Size
|
— | 51-200 | 11-50 | 2-10 |
|
City
|
San Francisco, California | Huntsville, AL | Los Angeles, California | West Chester, Pennsylvania |
|
Country
|
United States | United States | United States | United States |
|
Skills & Keywords
Comparing with main company
|
14 Total Skills
Intraoperative Imaging
Cancer Surgery
Molecular Imaging
Biotechnology
Surgical Imaging
Oncology
Cancer Detection
intraoperative imaging
optics
cancer
imaging
integrated circuits
biotechnology
cancer surgery
|
18 Total
18 Unique
Unique Skills:
agriscience
bioinformatics
clinical genomics
computational biology
epigenetics
genetic testing
+12
|
10 Total
10 Unique
Unique Skills:
accelerator physics
microscopy
nonlinear
photonics
physical chemistry
quantum
+4
|
18 Total
18 Unique
Unique Skills:
biomarkers
brain cancer
cardiac
cell imaging
collaboration
colorectal
+12
|
Other organizations in the same industry
This company is also known as